On June 19-21, 2023, the 13th Health & Nutraceutical China(HNC) held in Shanghai National Convention and Exhibition Center concluded successfully. HNC, as a landmark brand event in the field of health, shared 150,000
On June 19-21, 2023, the 13th Health & Nutraceutical China(HNC) held in Shanghai National Convention and Exhibition Center concluded successfully. HNC, as a landmark brand event in the field of health, shared 150,000
On June 19-21, 2023, the 21st World Pharmaceutical Raw Materials China Exhibition (CPHI China) in conjunction with the 16th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (PMEC China)
CFS is a disorder of unknown etiology, consisting of prolonged, debilitating fatigue, and a multitude of symptoms including neurocognitive dysfunction, flu-like symptoms, myalgia, weakness, arthralgia, low-grade fev
Alcohol is a kind of psychoactive substance, which has been commonly used in several cultures for centuries. Alcohol intake is the main cause of acute liver injury and chronic liver disease. Alcoholism can accelerate man
Stevia (Stevia rebaudiana Bertoni), a perennial shrub of the Compositae family, is cultivated in many regions across the world. It is famous for its sweetness, which is due to the presence of steviol glycosides, having 1
Stevioside is a natural sweetener derived from the stevia plant. It has a high sweetness intensity and low-calorie content, making it attractive for diabetics and others on carbohydrate-controlled diets. However, stevios
On April 7th, 2023, KPMG China hosted the second Biotech Innovation 50 Enterprises award ceremony online, with CITIC Securities as a co-organizer. Bontac impressed the panel with its strong R&D capabilities and
Highlight: In chronic HBV infection elevated ROS production is associated to high DNA damage in HBV-specific CD8 T cells - Response to DNA damage is dysfunctional - Up-regulation of CD38 and persistent activatio
In the pass decades days, the Open AI and the amazing founder behind AI application both captured attention world widely. But recently, as MIT Technology Review reported, the OpenAI CEO Sam Altman has turned ou
